Evidence map›Paper›PMID 36909666›Full record

ArticleBone reports2023

Bone marrow lesions in osteoarthritis: From basic science to clinical implications.

Xiaorui Shi, Yiying Mai, Xiaofeng Fang, Zhiqiang Wang, Song Xue, Haowei Chen, Qin Dang, Xiaoshuai Wang, Su'an Tang, Changhai Ding and 1 more

Abstract read
In one paragraph

Article in Bone reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaorui ShiClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Yiying MaiClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Xiaofeng FangClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhiqiang WangClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Song XueClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Haowei ChenClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Qin DangClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Xiaoshuai WangClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Su'an TangClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Changhai DingClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zhaohua ZhuClinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is the most prevalent musculoskeletal disease characterized by multiple joint structure damages, including articular cartilage, subchondral bone and synovium, resulting in disability and economic burden. Bone marrow lesions (BMLs) are common and important magnetic resonance imaging (MRI) features in OA patients. Basic and clinical research on subchondral BMLs in the pathogenesis of OA has been a hotspot. New evidence shows that subchondral bone degeneration, including BML and angiogenesis, occurs not only at or after cartilage degeneration, but even earlier than cartilage degeneration. Although BMLs are recognized as important biomarkers for OA, their exact roles in the pathogenesis of OA are still unclear, and disputes about the clinical impact and treatment of BMLs remain. This review summarizes the current basic and clinical research progress of BMLs. We particularly focus on molecular pathways, cellular abnormalities and microenvironmental changes of subchondral bone that contributed to the formation of BMLs, and emphasize the crosstalk between subchondral bone and cartilage in OA development. Finally, potential therapeutic strategies targeting BMLs in OA are discussed, which provides novel strategies for OA treatment.

Indexed as

Bone marrow lesionsCrosstalkMicroenvironmentOsteoarthritisSubchondral boneTreatment

Identifiers

PMID36909666
PMCPMC9996250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.